Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Statins
100%
Ischemia-reperfusion Injury
100%
Potential Interaction
100%
Antiplatelet Drugs
100%
Dipyridamole
50%
Simvastatin
50%
Infarct Size
50%
Inducible Nitric Oxide Synthase
33%
Cyclooxygenase-2
33%
NOS2
33%
Phosphoinositide 3-kinase (PI3K)
33%
Protective Effect
33%
Aspirin
33%
Endothelial Nitric Oxide Synthase (eNOS)
33%
Myocardial Infarct Size
33%
Liming Effect
33%
Low-dose Aspirin
33%
Ischemia
16%
Therapeutic Agents
16%
High Dose
16%
Adenosine
16%
Adenosine Receptors
16%
Downstream Effectors
16%
Acute Myocardial Infarction
16%
Antiplatelet Agents
16%
Cilostazol
16%
Ectonucleotidases
16%
Phosphodiesterase 3 Inhibitor
16%
Antiplatelet
16%
Reuptake Inhibitors
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Reperfusion Injury
100%
Antithrombocytic Agent
100%
Acetylsalicylic Acid
66%
Inducible Nitric Oxide Synthase
66%
Infarction
50%
Simvastatin
50%
Dipyridamole
50%
Low Drug Dose
50%
Cyclooxygenase 2
33%
Heart Infarction
33%
Phosphatidylinositol 3 Kinase
33%
Endothelial Nitric Oxide Synthase
33%
Ischemia
16%
Adenosine
16%
Adenosine Receptor
16%
Acute Heart Infarction
16%
Reuptake Inhibitor
16%
Protein Kinase B
16%
Cilostazol
16%
5' Nucleotidase
16%
Phosphodiesterase III Inhibitor
16%
Antiplatelet
16%